Skip to main content

Find Clinical Trials

Home
Conditions
Radioactive Iodine-refractory Differentiated Thyroid Cancer

Clinical trial condition

Radioactive Iodine-refractory Differentiated Thyroid Cancer

Explore clinical trials studying Radioactive Iodine-refractory Differentiated Thyroid Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Radioactive Iodine-refractory Differentiated Thyroid Cancer trial results

Active, Not Recruiting

Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer

NCT04560127

Conditions: Radioactive Iodine-refractory Differentiated Thyroid Cancer
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details